View Clinical Trial (Medical Research Study)

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine - NCT00856297-15241(Clinical Trial 276000)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Pittsburgh
State:  
PA
Zip Code: 15241
Conditions: Meningococcal Meningitis
Purpose: The primary objective is to evaluate the persistence of bactericidal antibodies in adolescents previously enrolled in the V59P13 study who received either Novartis MenACWY Conjugate Vaccine or commercial available MenACWY conjugate vaccine. The study will also enroll age-matched subjects who have never received any other meningococcal vaccine (naïve subjects) to serve as an additional control group.
Study summary:
Criteria: Inclusion Criteria: - Subjects enrolled in V59P13 - Healthy, who have completed the V59P13 study and are in good health; - Naïve subjects - Healthy children aged-matched with subjects enrolled in V59P13 trial. Exclusion Criteria: Subjects enrolled in V59P13: - who received any meningococcal vaccine after V59P13 trial; - who have had a previous confirmed or suspected disease caused by N. meningitidis; - who have had household contact with and/or intimate exposure to an individual with culture-proven N. meningitidis (serogroups A, C, W135, or Y); - Subjects with any serious, acute or chronic progressive disease. Naïve subjects - who previously received any meningococcal vaccine; - who have had a previous confirmed or suspected disease caused by N. meningitidis; - who have had household contact with and/or intimate exposure to an individual with culture-proven N. meningitidis (serogroups A, C, W135, or Y); - Subjects with any serious, acute or chronic progressive disease.
Study is available at: Primary Physicians Research, Inc.
Pittsburgh, PA 15241
United States

Primary Contact:
Novartis Drug Information Services
Phone: +1 800 244 7668
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.